Colorectal Cancer Metastatic
212
51
68
64
Key Insights
Highlights
Success Rate
74% trial completion
Published Results
25 trials with published results (12%)
Research Maturity
64 completed trials (30% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.4%
22 terminated out of 212 trials
74.4%
-12.2% vs benchmark
10%
21 trials in Phase 3/4
39%
25 of 64 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 64 completed trials
Clinical Trials (212)
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy
Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients
FOLFIRI Plus Bevacizuamb and QL1706 in Second-Line Treatment for mCRC
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
Galunisertib Combined With Capecitabine in Advanced CRC With PM
Registry Platform Colorectal Cancer
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer
China Metastatic Liver Cancer Clinical Registry Cohort Database
Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.